Epstein-Barr virus involvement in T-cell malignancy: Significance in adult T-cell leukemia

Leukemia and Lymphoma

Volumn 33, Issue 5-6, 1999, Pages 451-458

  Ohtsubo, Hideo ^a   Arima, Naomichi ^a,b   Tei, Chuwa ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

ATL; CD21; EBV; HTLV I; Leukemogenesis; Tax

Indexed keywords

COMPLEMENT COMPONENT C3D RECEPTOR; VIRUS RECEPTOR;

EPSTEIN BARR VIRUS; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; LEUKEMOGENESIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; T CELL LEUKEMIA; T CELL LYMPHOMA; T LYMPHOCYTE; VIRUS CARCINOGENESIS; VIRUS CELL TRANSFORMATION; VIRUS INFECTION;

EID: 0032905576     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199909058450     Document Type: Review

References (71)

1. Epstein, M. A., Achong, B. G., and Barr, Y. M. (1964) Virus particles in cultured lyhmphoblasts from Burkitt's lymphoma. Lancet 1:702-703.
2. Klein, E., Ernberg, I., Masucci, M. G. et al (1981) T cell response to B cells and Epstein-Barr virus antigens infectious mononucleosis. Cancer Res., 41, 4210-4215.
3. Sumaya, C. V. and Ench, Y. (1986) Epstein-Barr virus infections in family: the role of children with infectious mononucleosis. J. Infect. Dis., 154, 842-850.
4. Ho, M., Miller, G., Atchinson, R. W. et al. (1985) Epstein-Barr virus infection and DNA hybridization studies in post-transplantation lymphoma and lymphoproliferative lesions: the role of primary infection. J. Infect Dis., 152, 876-886.
5. Shapiro, R. S., McClain, K., Frizzera, G. et al. (1988) Epstein-Barr virus-associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood, 71, 1234-1243.
6. Hanto, D. W., Frizzera, G., Gajl-eczalska, K. J. et al (1982) Epstein-Barr virus induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B cell proliferation. N Engl J Med, 306, 913-918.
7. Borisch Chappuis, B., Muller, H., Stutte, J. et al (1990) Identification of EBV DNA in lymph nodes and lymphomas in AIDS. Virch. Arch. B., 58, 199-205.
8. Jones, J. F., Shurin, S., Abramowsky, C., Tubbs, RR. et al. (1988) T cell lymphomas contaiing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infection. N Engl. J Med, 318, 733-741.
9. Fingeroth, J. D., Benedict, M. A., Levy, D. N., Strominger, J. L (1989) Identificatin of murine complement receptor type 2. Proc Natl Acad Sci USA, 86, 242-46.
10. Mittler, R. S., Talle, M. A., Carpenter, K., Rao, P. E., Goldstein, G. (1983) Generation and characterization of monoclonal antibodies reactive with human B lymphocytes. J. Immunol. 131, 1754-61.
11. Moore, M. D., Cooper, N. R., Tack, B. F., Nemerow, G. R. (1987) Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes. Proc Nal Acad Sci. USA, 84, 9194-98.
12. Kai, C., Okada, N., and Okada, H. (1988) Expression of CR2 (CD3d receptor) on the cell membranes of adult T cell leukemia. Jpn J Cancer Res, 79, 805-8.
13. Yoshida, M., Miyoshi, I., and Hinuma, Y. (1982) Isolation and characterization of retrovirus (ATLV) from cell lines of adult T cell leukemia and its implication in the disease. Proc Natl Acad Sci USA, 79, 2031-35.
14. Okamoto, T., Ohno, Y., Tsugane, S., Watanabe, S., Shimoyama, M., Tajima, K., Miwa, M., and Shimotohno, K. (1989). Multi-step carcinogenesis model for adult T-cell leukemia. Jpn J Cancer Res, 80, 191-95.
15. Nonoyama, M., Huang, CH., Pagano, JS., Klein, G., Singh, S. (1973) DNA of Epstein-Barr virus detected in tissue of Burkitt's lymphoma and nasopharyngeal carcinoma. Proc Natl Acad Sci USA, 70, 3265-68.
16. Klein, G., Giovanella, B. C., Lindahl, T., Fialkow, P. J., Singh, S., and Stehlin, J. S. (1974) Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with anaplastic carcinoma of the nasopharynx. Proc Natl Acad Sci USA, 71, 4737-41.
17. Weiss, L. M., Strickler, J. G., Warnke, R. A., et al. (1987) Epstein-Barr virus DNA in tissues of Hodgkin's disease. Am J Pathol 129, 86-89.
18. Weiss, L. M. Movahed, L. A., Warnke, R. A., et al. (1989) Detection of Epstein-Barr virus genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med. 320, 502-506.
19. Kawa-Ha, K., Ishihara, S., Ninomiya, T., Yumura-Yagi, K., Hara., J., Murayama, F., Tawa, A., and Hirai, K. (1989) CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest, 84, 51-55.
20. Sample, J. T. (1994) Epstein-Barr virus - Molecular biology. In "Encyclopedia of Virology," ed. R.G. Webster and A. Granoff, pp.410-416. Academic Press New York.
21. Rawlins, D. R., Milman, G., Hayward, S. D., and Hayward, G. S. (1985) Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region. Cell, 42, 859-68.
22. Sixbewy, J. W., Shirley, P., Sloas, M., Raab-Traub, N, and Israele, V. (1991) A transformation-incompetent, nuclear antigen 2-depleted Epstein-Barr virus associated with replicative infection. J Infect Dis, 163, 1008-15.
23. Kaye, K. M., Izumi, K., and Kieff, E. (1993) Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci USA, 90, 9150-54.
24. Tomkinson, B., Robertson, E., and Kieff, E. (1993) Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J Virol 67, 2014-25.
25. Swaminathan, S., Tomkinson, B., and Kieff, E. (1991) Recombiant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro. Proc Natl Acad Sci USA, 88, 1546-50.
26. Cordier, M., Calender, A., Billaud, M., Zimber, U., Rousselet, G., Pavlisyh, O., Banchereau, J., Tursz, T., Bornkamm, G., and Lenoir, G. M. (1990) Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3H1 genome. J Virol, 64, 1002-13.
27. Kanno, H., Yasunaga, Y., Ohsawa, M., Taniwaki, M., Iuchi, K., Naka, N., Toriaki, K., Shimoyama, M., and Aozasa, K. (1996) Exression of Epstein-Barr virus latent infection gene and oncogenes in lymphoma cell lines derived from pyothorax-associated lymphoma. Int J Cancer, 67, 86-94.
28. Szekeryi, L., Selivanova, G., Magnusson, K. P. et al. (1993) EBNA-5, an Epstein-Barr virus-encoded antigen, binds to the retinoblastoma and p53 proteins. Proc Natl Acad Sci USA, 90, 5455-59.
29. Peng, M., and Lundgren, E. (1992) Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis. Oncogene, 7, 1775-82.
30. Roberts, M. L., and Cooper, N. R. (1998) Activatin of a ras-MAPK-dependent pathway by Epstein-Barr virus latent membrane protein 1 is essential for cellular transformation. Virology, 240, 93-99.
31. Laherty, C. D., Hu, H. M., Opipari, A. W., Wang, F., Dixit, V. M. (1992) The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expressin by activating nuclear factor kappa B. J Biol Chem., 267, 24157-60.
32. Henderson, S., Rowe, M., Gregory, C., Croom-Carter, D., Wang, F., Longnecker, R., Kieff, E., and Rickinson, A. (1991) Inductin of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell, 65, 1107-15.
33. Harabuchi, Y., Yamanaka, N., Kataura, A., Imai, S., Kinoshita, T., Mizuno, F., and Osato, T. (1990) Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet, 335, 128-130.
34. Pan, L., Diss, T. C., Peng, H., Lu, Q, Wotherspoon, A. C., Thomas, J. A., and Isaacson, P. G. (1993) Epstein-Barr virus (EBV) in enteropathy-associated T-cell lymphoma (EATL). J Pathol, 170, 137-43.
35. Tsai, T. F., Su, I. J., Lu, Y. C., Cheng, A. L., Yen, H. P., Hsieh, H. C., Tien, H. F., Chen, J. S., and Uen, W. C. (1992) Cutaneous angiocentric T-cell lymphoma associated with Epstein-Barr virus. J Am Acad Dermatol, 26, 31-38.
36. Su, I. J., and Hsieh H.C. (1992) Clinicopathological spectrum of Epstein-Barr virus-associated T cell malignancies. Leukemia and Lymphoma, 7, 47-53.
37. Su, I. J., Hsieh, H. C., Lin, K. H., Uen, W. C., Kao, C. L., Chen, C. J., Cheng, A. L., Kadin, M.. E., and Chen, J. Y. (1991) Aggressive peripheral T-cell lymphomas containing Epstein-Barr virus DNA: a clinicopathologic and molecular analysis. Blood, 77, 799-808.
38. Cheng, A. L., Su, I. J., Chen, Y. C., Uen, W. C., and Wang, C. H. (1993) Characteristic clinicopathologic features of Epstein-Barr virus-associated peripheral T-cell lymphoma, Cancer 72, 909-1016.
39. Anagnostopoulos, I., Hummel, M., Kaudewitz, P., Korbjuhn, P., Leoncini, L., and Stein, M. (1996) Low incidence of Epstein-Barr virus presence in primary cutaneous T-cell lymphoproliferations. Br J Dermatol, 134, 276-81.
40. Allday, M. J., Crawford, D. H., and Griffin, B. E. (1989) Epstein-Barr virus latent gene expressin during the initiation of B cell immortalization. J Gen Virol, 70, 1755-64.
41. Niedobitek, G., Agathanggelou, A, Rowe, M., Jones, E. L., Jones, D. B., Turyagnuma, P., Oryema, J., Wright, D. H., Young, L. S. (1995) Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma. Blood, 86, 659-65.
42. Young, L. S., Dawson, C. W., Clark, D., Rupani, H., Busson, P., Tursz, T., Johnson, A., and Rickinson, A. B. (1988) Epstein-Barr virus gene expression in nasopharyngeal carcinoma.J Gen Virol, 69, 1051-65.
43. Pallesen, G., Hamilton-Dutoit, S. J., Rowe, M., Lisse, I., Ralfkiaer, E., Sandvej, K., and Young, L. S. (1991) Expression of Epstein-Barr virus replicative proteins in AIDS-related non-Hodgkin's lymphoma cells. J Pathol, 165, 289-99.
44. Chen, C.L., Sadler, R. H., Walling, D. M., Su, I. J., Hsieh, H. C., and RaabTraub, N. (1993) Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas. J Virol, 67, 6303-08.
45. Woisetschlaeger, M., Strominger, J. L., and Speck, S. H. (1989) Mutually exclusive use of viral promoters in Epstein-Barr virus latently infected lymphocytes. Proc Natl Acad Sci USA, 86, 6498-502.
46. Brooks, L., Yao, Q. Y., Rickinson, A. B., and Young, L. S. (1992) Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcript. J Virol, 66, 2689-97.
47. Koizumi, S., Zhang, X. K., Imai, S., Sigiura, M., Usui, N., Osato, T. (1992) Infection of the HTLV-I-harbouring T-lymphoblastoid line MT-2 by Epstein-Barr virus. Virology, 188, 859-63.
48. Tsoukas, C. D., and Lambris, J. D. (1988) Expression of CR2/EBV receptors on human thymocytes detected by monoclonal antibodies. Eur J Immunol, 18, 1299-302.
49. Fischer, E., Delibrias, C., and Kazatchkine, M. D. (1991) Expression of CR2 (the C3dR/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. J Immunol, 146, 865-69.
50. Ohtsubo, H., Arima, N., Matsushita, K., Hidaka, S., Fujiwara, H., Arimura K., Kukita, T., Fukumori, J., Matsumoto, T., Eizuru, Y., and Tanaka, H. (1997) Human T lymphotropic virius-type I Tax induction of CD21/Epstein-Barr virus receptor expression on T cells and its significance in leukemogenesis of adult T cell leukema. Exp Hematol, 25, 1246-52.
51. Rayhel, E. J., Dehoff, M. H., and Holers, V. M. (1991) Characterization of the human complement receptor 1 (CR2, CD21) promoter reveals sequences shared with regulatory regions of other developmentally restricted B cell proteins. J Immunol, 146, 2021-26.
52. Imai, S. (1990) Virological and immunological studies on inapparent Epstein-Barr virus infection in healthy individuals: In comparison to immunosuppressed patients and patients with infectious mononucleosis. Hokkaido Igaku Zasshi, 65, 481-92.
53. Seiki, M., Hattori, S., and Yoshida, M. (1982) Human adult T-cell leukemia virus: molecular cloning of the provirus DNA and the unique terminal structure. Proc Natl Acad Sci USA, 79, 6899-902.
54. Chen, I.S.Y., Slamon, D.J., Rosenblatt, J.D., Shah, N.P. Quan, S.G. and Wachsman W. (1985) The X gene is essential for HTLV replication. Science, 299, 54-58.
55. Seiki, M., Hikikoshi A., Taniguchi T. and Yoshida, M. (1985) Expression of the pX gene of HTLV-I: general splicing mechanims in the HTLV family. Science 228, 1532-34.
56. Inoue, J.-K., Yoshida, M., and Seiki, M. (1987) Transcriptional (p40x) and post-transcriptional (p27x-III) regulators are required for expression of the HTLV-I genes. Proc Natl Acad Sci USA, 84, 3653-57.
57. x encoded by human T-cell leukemia virus type I. EMBO J, 5, 2883-88.
58. Cross, S. L., Feinberg, M. B., Wolf, J. B., Holbrook, N. J., Wong-Staal, F., and Leonard, W. J. (1987) Regulation of the human interleukin-2 receptor a chain promoter: activation of a nonfunctional promoter by the transactivator gene of HTLV-I. Cell, 49, 47-56.
59. Fujii, M., Sassone-Corsi, P., and Verma, I. M. (1988) c-fos promoter transactivation by the tax protein of human T-cell leukemia virus type I. Proc Natl Acad Sci USA, 85, 8526-30.
60. Ballard, D.W., Bohnlein, E., Lowenthal, J.W., Wano, Y, Franza, B.R., and Greene W.C. (1988) HTLV-I tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene. Science, 241, 1652-55.
61. Leung, K, Nabel, G. J. (1988) HTLV-I transactivator induced interleukin-2 receptor expression through and NF-kappa B-like factor. Nature, 333, 776-78
62. Ruben, S., Poteat, H., Tan, T. H., Kawakami, K., Roeder, R., Haseltine, W., Rosen, C.A. (1988) Cellular transcription factors and regulation of IL-2 receptor gene expression by HTLV-I tax gene product. Science, 241, 89-92.
63. x -responsive 21 base-pair sequence.J Virol, 62, 4499-509.
64. x and T3/Ti complex triggering. Cell, 48, 343-50.
65. Yokota, J., and Sugimura, T. (1993) Multile steps in carcinogenesis involving alterations of multiple tumor suppressor genes. FASEB J, 7, 920-25.
66. Sakashita, A., Hattori, T., Miller, C. W., Suzushima, H., Asou, N., Takatsuki, K., and Koeffler, H. P. (1992) Mutations of the p53 gene in adult T-cell leukemia. Blood, 79, 477-80.
67. Hatta, Y., Hirama, T., Miller, C. W., Yamada, Y., Tomonaga, M., and Koeffler, H. P. (1995) Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cellleukemia. Blood, 85, 2699-704.
68. Maeda, M., Shimiziui, A., Ikuta, K., Okamoto, H., Kashihara, M., Uchiyama, T., Honjo, T., and Yodoi, J. (1985) Origin of human T-lymphotrophic virus I positive T cell lines in adult T cell leukemia. Analysis of T cell receptor gene rearrangement. J Exp Med, 162, 2169-74.
69. Kawano, F., Yamaguchi, K., Nishimura, H., Tsuda, H., and Takatsuki, K. (1985) Variation in the clincial courses of adult T-cell leukemia. Cancer 55, 851-56.
70. Tokunaga, M., Imai, S., Uemura, Y., Tokudome, T., Osato, T., and Sato, E. (1993) Epstein-Barr virus in adult T-cell leukemia/lymphoma. Am J Pathol, 143, 1263-68.
71. Arima, N. (1997) Autonomous and interleukin-2-responsive growth of leukemic cells in adult T-cell leukemia (ATL): a review of the clinical significance and molecular basis of ATL cell growth. Leukemia and Lymphoma, 26, 479-87.